Kits and methods for induction of cardioversion in subjects with atrial arrhythmias
AssigneeInCarda Therapeutics, Inc.
InventorsLuiz Belardinelli, Carlos Schuler, Miguel Guzman
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using potassium channel inhibitors and class I antiarrhythmic agents. Also disclosed herein are methods and kits for treating a heart condition via an intravenously, orally, or inhalationally administered fixed-dose combination of a sodium channel blocker and a class I antiarrhythmic agent.
Claims24
A method of treating a subject suffering from atrial arrhythmia, comprising intravenously administering to said subject a pharmaceutical composition, wherein the pharmaceutical composition comprises
- a sodium channel blocker that is flecainide or a pharmaceutically acceptable salt thereof;
- and
- a potassium channel blocker selected from the group consisting of:
- ibutilide or a pharmaceutically acceptable salt thereof, and dofetilide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.